The National Vaccine Taskforce is now preparing for the nationwide rollout of the vaccine - and is due to submit its implementation plan to Government on Friday, December 11th.
The UK medicines regulator is now assessing two vaccines - one developed by Pfizer and BioNTech, the other by Oxford University and AstraZeneca - to see if they are safe and effective.
Interim data is reported from the last-stage trail of Moderna's experimental vaccine is 94.5% effective in preventing Covid-19.
The positive developments around the coronavirus vaccine are likely to bode well for the risk sentiment and the pound, as the EU-UK push towards reaching a Brexit trade deal as early as the next week.More news: 49ers could share Cardinals' stadium amid new restrictions
"Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally".
"The Moderna vaccine has been an important addition to our portfolio, and securing an additional 2 million doses adds to the protection we can provide to the public to end the epidemic".
Mr Jahavi, who is also a business minister, said he was happy to be in charge when the vaccine rollout happened.
According to the statement, the new deal, signed on Sunday, brings the total number of Moderna vaccine doses secured for the United Kingdom to 7 million.
Astrogeneca vaccine needs "more than a press release" to evaluate test results.More news: Star Wars' Darth Vader aka David Prowse dies at 85
Dr. Levine says the Moderna vaccine will be ready between late December and early January.
"The Johnson & Johnson vaccine would only be one dose".
However, Bloomberg has reported that AstraZeneca is now looking to perform another global trial of the vaccine candidate to confirm this 90pc efficacy rate, separate from another study analysing the vaccine currently underway in the US.
That includes AstraZeneca recently announcing its vaccine candidate was 70-90% effective, depending on dosage. Each person requires two doses of the vaccine to be treated.More news: New Zealand beat West Indies in first T20 global
American authorities confirmed that the results were unclear and, to make matters worse, he was the head of the main federal vaccination initiative, not the company, the first to reveal that the most promising results of the vaccine were not reflecting the data of people elderly women.